Sterling Infrastructure (SYBX) Investor Presentation - Slideshow

© 2023 SYNLOGIC. CORPORATE PRESENTATION. ALL RIGHTS RESERVED. | 36 LS mean change over Placebo, +/- 90% CI, all days baseline and treated. 1. Proof-of-Concept Study of Oxalate-Consuming Synthetic Biotic Medicine SYNB8802 in Enteric Hyperoxaluria after Roux-en-Y Surgery, American Society of Nephrology Kidney Week, November 5, 2021 | --- | --- | --- | --- | --- | --- | --- | |-------|------------------------------|-------|-------|-----------|---------------------|-----------------------| | | | | | | | | | | U ...